1394 related articles for article (PubMed ID: 33693551)
21. Comparison of influenza- and COVID-19-associated pulmonary aspergillosis in China.
Zhao J; Zhuo X; Pu D; Fan G; Lu B; Cao B
Eur J Clin Microbiol Infect Dis; 2024 Apr; 43(4):683-692. PubMed ID: 38326545
[TBL] [Abstract][Full Text] [Related]
22. Clinical courses and outcomes of COVID-19 associated pulmonary aspergillosis in 168 patients with the SARS-CoV-2 omicron variant.
Wang Y; Yao Y; Zhang Q; Chen H; He Y; Hu K
BMC Infect Dis; 2024 Jan; 24(1):117. PubMed ID: 38263011
[TBL] [Abstract][Full Text] [Related]
23. Invasive pulmonary aspergillosis in critically ill patients with severe COVID-19 pneumonia: Results from the prospective AspCOVID-19 study.
Lahmer T; Kriescher S; Herner A; Rothe K; Spinner CD; Schneider J; Mayer U; Neuenhahn M; Hoffmann D; Geisler F; Heim M; Schneider G; Schmid RM; Huber W; Rasch S
PLoS One; 2021; 16(3):e0238825. PubMed ID: 33730058
[TBL] [Abstract][Full Text] [Related]
24. COVID-19-associated pulmonary aspergillosis in a tertiary care center in Shenzhen City.
Jiang Z; Chen S; Zhu Q; Xiao Y; Qu J
J Infect Public Health; 2022 Feb; 15(2):222-227. PubMed ID: 35032951
[TBL] [Abstract][Full Text] [Related]
25. Usefulness of Sōna Aspergillus Galactomannan LFA with digital readout as diagnostic and as screening tool of COVID-19 associated pulmonary aspergillosis in critically ill patients. Data from a multicenter prospective study performed in Argentina.
Giusiano G; Fernández NB; Vitale RG; Alvarez C; Ochiuzzi ME; Santiso G; Cabeza MS; Tracogna F; Farías L; Afeltra J; Noblega LM; Giuliano CV; Garcia-Effron G
Med Mycol; 2022 May; 60(5):. PubMed ID: 35394043
[TBL] [Abstract][Full Text] [Related]
26. Risk Factors for Invasive Aspergillosis in Patients Admitted to the Intensive Care Unit With Coronavirus Disease 2019: A Multicenter Retrospective Study.
Xu J; Yang X; Lv Z; Zhou T; Liu H; Zou X; Cao F; Zhang L; Liu B; Chen W; Yu Y; Shu H; Yuan S; Hu M; Huang C; Shang Y
Front Med (Lausanne); 2021; 8():753659. PubMed ID: 34869450
[No Abstract] [Full Text] [Related]
27. Invasive pulmonary aspergillosis in the COVID-19 era: An expected new entity.
Machado M; Valerio M; Álvarez-Uría A; Olmedo M; Veintimilla C; Padilla B; De la Villa S; Guinea J; Escribano P; Ruiz-Serrano MJ; Reigadas E; Alonso R; Guerrero JE; Hortal J; Bouza E; Muñoz P;
Mycoses; 2021 Feb; 64(2):132-143. PubMed ID: 33210776
[TBL] [Abstract][Full Text] [Related]
28. Regional Impact of COVID-19-Associated Pulmonary Aspergillosis (CAPA) during the First Wave.
Bentvelsen RG; Arkel ALEV; Rijpstra TA; Kant MKM; Brugge SVS; Loth DW; Van Wijngaarden P; Mée AWFD; Yick DCY; Diederen BMW; Wever PC; Leenders ACAP; Van Dommelen L; Groot KH; Van den Bijllaardt W; Verweij PE
J Fungi (Basel); 2022 Jan; 8(2):. PubMed ID: 35205851
[TBL] [Abstract][Full Text] [Related]
29. Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study.
Hatzl S; Reisinger AC; Posch F; Prattes J; Stradner M; Pilz S; Eller P; Schoerghuber M; Toller W; Gorkiewicz G; Metnitz P; Rief M; Prüller F; Rosenkranz AR; Valentin T; Krause R; Hoenigl M; Schilcher G
Crit Care; 2021 Sep; 25(1):335. PubMed ID: 34526087
[TBL] [Abstract][Full Text] [Related]
30. Multinational Observational Cohort Study of COVID-19-Associated Pulmonary Aspergillosis
Janssen NAF; Nyga R; Vanderbeke L; Jacobs C; Ergün M; Buil JB; van Dijk K; Altenburg J; Bouman CSC; van der Spoel HI; Rijnders BJA; Dunbar A; Schouten JA; Lagrou K; Bourgeois M; Reynders M; van Regenmortel N; Rutsaert L; Lormans P; Feys S; Debavaye Y; Tamion F; Costa D; Maizel J; Dupont H; Chouaki T; Nseir S; Sendid B; Brüggemann RJM; van de Veerdonk FL; Wauters J; Verweij PE
Emerg Infect Dis; 2021 Nov; 27(11):2892-2898. PubMed ID: 34519638
[TBL] [Abstract][Full Text] [Related]
31. COVID-19-Associated Invasive Aspergillosis: Data from the UK National Mycology Reference Laboratory.
Borman AM; Palmer MD; Fraser M; Patterson Z; Mann C; Oliver D; Linton CJ; Gough M; Brown P; Dzietczyk A; Hedley M; McLachlan S; King J; Johnson EM
J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33087440
[TBL] [Abstract][Full Text] [Related]
32. Corticosteroids as risk factor for COVID-19-associated pulmonary aspergillosis in intensive care patients.
Leistner R; Schroeter L; Adam T; Poddubnyy D; Stegemann M; Siegmund B; Maechler F; Geffers C; Schwab F; Gastmeier P; Treskatsch S; Angermair S; Schneider T
Crit Care; 2022 Jan; 26(1):30. PubMed ID: 35090528
[TBL] [Abstract][Full Text] [Related]
33. Risk of Coronavirus Disease 2019-Associated Pulmonary Aspergillosis Based on Corticosteroid Duration in Intensive Care Patients.
Shah M; Reveles K; Moote R; Hand E; Kellogg Iii D; Attridge RL; Maselli DJ; Gutierrez GC
Open Forum Infect Dis; 2023 Mar; 10(3):ofad062. PubMed ID: 36879627
[TBL] [Abstract][Full Text] [Related]
34. Significance of Aspergillus spp. isolation in defining cases of COVID-19 Associated Pulmonary Aspergillosis - CAPA.
Cocio TA; Siqueira LPM; Riciluca KCT; Gimenes VMF; de Andrade TS; Benard G; Martínez R; Bollela VR
Braz J Infect Dis; 2023; 27(4):102793. PubMed ID: 37507102
[TBL] [Abstract][Full Text] [Related]
35. [COVID-19-associated pulmonary aspergillosis in critically ill patients: experience of a Chilean public hospital].
Araya-Rojas F; Lasso-Barreto M
Rev Chilena Infectol; 2021 Dec; 38(6):754-760. PubMed ID: 35506848
[TBL] [Abstract][Full Text] [Related]
36. Covid-19-associated pulmonary aspergillosis in mechanically ventilated patients: incidence and outcome in a French multicenter observational cohort (APICOVID).
Desmedt L; Raymond M; Le Thuaut A; Asfar P; Darreau C; Reizine F; Colin G; Auchabie J; Lorber J; La Combe B; Kergoat P; Hourmant B; Delbove A; Frérou A; Morin J; Ergreteau PY; Seguin P; Martin M; Reignier J; Lascarrou JB; Canet E
Ann Intensive Care; 2024 Jan; 14(1):17. PubMed ID: 38285382
[TBL] [Abstract][Full Text] [Related]
37. Association between Pulmonary Aspergillosis and
Caciagli V; Coloretti I; Talamonti M; Farinelli C; Gatto I; Biagioni E; Sarti M; Franceschini E; Meschiari M; Mussini C; Tonelli R; Clini E; Girardis M; Busani S; Modena Covid-Working Group
Viruses; 2023 Nov; 15(11):. PubMed ID: 38005936
[TBL] [Abstract][Full Text] [Related]
38. Risk factors for COVID-19-associated pulmonary aspergillosis: a systematic review and meta-analysis.
Gioia F; Walti LN; Orchanian-Cheff A; Husain S
Lancet Respir Med; 2024 Mar; 12(3):207-216. PubMed ID: 38185135
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of co-existent COVID-19-associated pulmonary aspergillosis (CAPA) and its impact on early mortality in patients with COVID-19-associated pulmonary mucormycosis (CAPM).
Muthu V; Agarwal R; Rudramurthy SM; Thangaraju D; Shevkani MR; Patel AK; Shastri PS; Tayade A; Bhandari S; Gella V; Savio J; Madan S; Hallur V; Maturu VN; Srinivasan A; Sethuraman N; Sibia RPS; Pujari S; Mehta R; Singhal T; Saxena P; Gupta V; Nagvekar V; Prayag P; Patel D; Xess I; Savaj P; Sehgal IS; Panda N; Rajagopal GD; Parwani RS; Patel K; Deshmukh A; Vyas A; Gandra RR; Sistla SK; Padaki PA; Ramar D; Panigrahi MK; Sarkar S; Rachagulla B; Vallandaramam P; Premachandran KP; Pawar S; Gugale P; Hosamani P; Dutt SN; Nair S; Kalpakkam H; Badhwar S; Kompella KK; Singla N; Navlakhe M; Prayag A; Singh G; Dhakecha P; Chakrabarti A
Mycoses; 2024 May; 67(5):e13745. PubMed ID: 38767273
[TBL] [Abstract][Full Text] [Related]
40. COVID-19-associated pulmonary aspergillosis (CAPA) in patients admitted with severe COVID-19 pneumonia: An observational study from Pakistan.
Nasir N; Farooqi J; Mahmood SF; Jabeen K
Mycoses; 2020 Aug; 63(8):766-770. PubMed ID: 32585069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
